Morgan Stanley released a research report on MINIMAX (00100.HK), initiating an "Outperform" rating with a target price of HK$990, corresponding to a 56x price-to-sales ratio for 2027. The company has rapidly iterated its large model to M2.7, significantly enhancing OpenClaw's performance and bringing it close to Sonnet 4.6 levels, strengthening its native AI capabilities and agent ecosystem development, thereby driving future token growth potential. (Jinshi)
Morgan Stanley upgrades MINIMAX to Overweight with a target price of HKD 990.
TechFlowShare
Summary
Morgan Stanley upgraded MINIMAX (00100.HK) to overweight with a target price of HKD 990, citing strong cryptocurrency price news. The firm noted that the company’s M2.7 model iteration has enhanced OpenClaw’s performance to near Sonnet4.6 levels. This advancement supports ecosystem growth through improved AI-native capabilities and agent development. The 56x price-to-sales ratio for 2027 reflects confidence in future token upside.
Source:Show original
Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information.
Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.